National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

By A. Hersh, M. Stefanick, R. Stafford. Journal of the American Medical Association (JAMA), 2004

1,021 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score (2006, background): “We excluded hormone replacement therapy because of the recent dramatic reduction in its prescription (18).”
Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States (2008, background): “Our report also highlights substantial use of a number of newer drugs brought to the market during the last several years (eg, ezetimibe and clopidogrel) and a decrease in the use of conjugated estrogens coinciding with the widely publicized Women’s Health Initiative Study findings about health risk”
[Guidelines on the management of stable angina pectoris: executive summary]. (2006, background): “New guidelines therefore recommend against routine use of HRT for chronic conditions(178) and current users have been advised to taper doses downwards towards discontinuation.(179)”